NASHVILLE, Tenn.--(BUSINESS WIRE)--Pinnacle Financial Partners (Nasdaq/NGS: PNFP) President and CEO Terry Turner and Synovus Financial Corp. (NYSE: SNV) Chairman, CEO and President Kevin Blair will participate in a joint fireside chat at the Goldman Sachs 2025 U.S. Financial Services Conference on Tuesday, Dec. 9 at 11:20 a.m. ET. They are expected to discuss the pending merger between Pinnacle and Synovus. A webcast of this event will be available on Pinnacle's investor relations website at in.

SANTA ROSA, Calif.--(BUSINESS WIRE)--Collaboration demonstrates end-to-end validation of Next Generation eCall functionality across 4G and 5G networks.

HAIFA, Israel--(BUSINESS WIRE)-- #proteantecs--proteanTecs®, a global leader in advanced analytics solutions for semiconductor health and performance monitoring, today announced the appointment of Mr. Noritaka Kojima as General Manager & Country Manager of proteanTecs Japan and the opening of its new Japan office in Yokohama, Kanagawa Prefecture, as part of its strategic expansion in the Japanese market. proteanTecs provides cutting-edge solutions that analyze Deep Data telemetry collected from within chi.

The vacation brand is ramping up on memory-making with adventure-filled lineups, including the world's best family vacation, Icon of the Seas, delivering unforgettable vacations from Galveston MIAMI , Nov. 12, 2025 /PRNewswire/ -- The ship that revolutionized family vacations is set to deliver the biggest adventures yet from Texas. The show-stopping Icon of the Seas will sail from Galveston for the first time starting August 2027, joining Royal Caribbean's new action-packed lineup of unforgettable getaways for the 2027-28 season.

TORONTO , Nov. 12, 2025 /PRNewswire/ -- Steve Hasker, president and chief executive officer of Thomson Reuters (TSX/Nasdaq: TRI) will present at the JP Morgan Ultimate Services Investor Conference on Tuesday, November 18, 2025, at 11:00 a.m. ET. The presentation may include forward-looking information.

MALVERN, Pa., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc. (NYSE: VSH) today broadens its optoelectronics portfolio with the introduction of a new high speed silicon PIN photodiode with enhanced sensitivity to visible and infrared light.

MOLINE, Ill. , Nov. 12, 2025 /PRNewswire/ -- Deere & Company (NYSE: DE) will hold its fourth quarter 2025 earnings call on Wednesday, 26 November, beginning at 9:00 a.m.

Current Chief Executive Officer, Brett Keller, to Retire from Priceline NORWALK, Conn. , Nov. 12, 2025 /PRNewswire/ -- Booking Holdings, the world's leading provider of online travel and related services, and parent company of consumer-facing brands including Booking.com , Priceline , Agoda , KAYAK and OpenTable , today announced that Brigit Zimmerman has been named Chief Executive Officer of Priceline effective January 1, 2026.

Nektar Therapeutics (NKTR) develops novel immunomodulatory drugs targeting autoimmune diseases and oncology, leveraging its expertise in immune system regulation. Recent Phase 2 results for Atopic Dermatitis met endpoints, validating NKTR's approach and boosting confidence in its platform's clinical potential. NKTR's pipeline includes rezpegaldesleukin for other indications, and NKTR-255 for cancer, addressing significant unmet medical needs.

ATLANTA, Nov. 12, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Firefly Aerospace Inc. (“Firefly”) (NASDAQ: FLY). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information regarding Firefly's business, operations, and prospects, including allegations that: (i) Firefly had overstated the demand and growth prospects for its Spacecraft Solutions offerings; (ii) Firefly had overstated the operational readiness and commercial viability of its Alpha rocket program; (iii) the foregoing, once revealed, would likely have a material negative impact on the Company; and (iv) as a result, the Offering …

LOS ANGELES, Nov. 12, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Soleno Therapeutics, Inc., (“Soleno" or the "Company") (NASDAQ: SLNO) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.

BBAI's $250M Ask Sage deal could reshape its AI role in defense, with platform growth and secure model deployment at the core.

The consensus price target hints at a 26.3% upside potential for Calix (CALX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

After reaching an important support level, Alto Ingredients, Inc. (ALTO) could be a good stock pick from a technical perspective. ALTO recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.

The mean of analysts' price targets for Klaviyo, Inc. (KVYO) points to a 47.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 33.4% in LifeStance Health (LFST). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The average of price targets set by Wall Street analysts indicates a potential upside of 104.5% in Rapport Therapeutics, Inc. (RAPP). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

The consensus price target hints at a 49.4% upside potential for Rezolute (RZLT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The mean of analysts' price targets for Helios Technologies (HLIO) points to a 26.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Microsoft stock (NASDAQ: MSFT) has surged by 20% this year, largely powered by robust Azure growth and the ongoing excitement surrounding the AI boom. However, following its rise past the $500 mark, a critical question emerges: Is the stock still a worthwhile purchase, or is a correction likely?